Investing.com - Journey Medical (NASDAQ: DERM) reported second quarter EPS of $-0.170, $0.03 worse than the analyst estimate of $-0.140. Revenue for the quarter came in at $14.86M versus the consensus estimate of $13.89M.
Journey Medical's stock price closed at $4.24. It is up 17.130% in the last 3 months and up 89.290% in the last 12 months.
Journey Medical saw positive EPS revisions and negative EPS revisions in the last 90 days. See Journey Medical's stock price’s past reactions to earnings here.
According to InvestingPro, Journey Medical's Financial Health score is "good performance".
Check out Journey Medical's recent earnings performance, and Journey Medical's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar